Supplemental material
Expert Review of Vaccines
Volume 23, 2024 - Issue 1
Open access
2,757
Views
0
CrossRef citations to date
0
Altmetric
Original Research
Predicted serotype-specific effectiveness of pneumococcal conjugate vaccines V114 and PCV20 against invasive pneumococcal disease in children
Josiah Rymana Quantitative Pharmacology and Pharmacometrics, Rahway, NJ, USAView further author information
, Jeffrey R. Sachsa Quantitative Pharmacology and Pharmacometrics, Rahway, NJ, USAView further author information
, Ka Lai Yeea Quantitative Pharmacology and Pharmacometrics, Rahway, NJ, USAView further author information
, Natalie Banniettisb Clinical Research, Rahway, NJ, USAView further author information
, Jessica Weaverc Center for Observational and Real-World Evidence,Merck & Co, Inc, Rahway, NJ, USACorrespondence[email protected]
View further author information
& View further author information
Thomas Weissc Center for Observational and Real-World Evidence,Merck & Co, Inc, Rahway, NJ, USAView further author information
Pages 60-68
|
Received 13 Oct 2023, Accepted 05 Dec 2023, Published online: 14 Dec 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.